stock
Pyxis Oncology Inc
NASDAQ | PYXS
1.91
USD
+$0.00
(+0.00%
)At Close (As of Sep 5, 2025)
$118.46M
Market Cap
-
P/E Ratio
-1.59
EPS
$5.39
52 Week High
$0.83
52 Week Low
HEALTHCARE
Sector
PYXS Chart
Recent Chart
Price Action
PYXS Technicals
PYXS Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $16M |
| Total Revenue | $16M |
| Cost Of Revenue | $475K |
| Costof Goods And Services Sold | $475K |
| Operating Income | -$89M |
| Selling General And Administrative | $25M |
| Research And Development | $59M |
| Operating Expenses | $105M |
| Investment Income Net | - |
| Net Interest Income | $7M |
| Interest Income | $7M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $3M |
| Income Before Tax | -$79M |
| Income Tax Expense | -$2.2M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$77M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$68M |
| Ebitda | -$66M |
| Net Income | -$77M |
Revenue & Profitability
Earnings Performance
PYXS Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $157M |
| Total Current Assets | $132M |
| Cash And Cash Equivalents At Carrying Value | $19M |
| Cash And Short Term Investments | $19M |
| Inventory | - |
| Current Net Receivables | - |
| Total Non Current Assets | $25M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $2.6M |
| Intangible Assets Excluding Goodwill | $2.6M |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $107M |
| Other Current Assets | $5.5M |
| Other Non Current Assets | - |
| Total Liabilities | $36M |
| Total Current Liabilities | $18M |
| Current Accounts Payable | $4.9M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $2.9M |
| Total Non Current Liabilities | $19M |
| Capital Lease Obligations | $20M |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $20M |
| Other Current Liabilities | $9.9M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $121M |
| Treasury Stock | - |
| Retained Earnings | -$364M |
| Common Stock | $60K |
| Common Stock Shares Outstanding | $58M |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$58M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $3M |
| Capital Expenditures | $237K |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | $8.2M |
| Cashflow From Financing | $59M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$77M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $16M |
| Total Revenue | $16M |
| Cost Of Revenue | $475K |
| Costof Goods And Services Sold | $475K |
| Operating Income | -$89M |
| Selling General And Administrative | $25M |
| Research And Development | $59M |
| Operating Expenses | $105M |
| Investment Income Net | - |
| Net Interest Income | $7M |
| Interest Income | $7M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $3M |
| Income Before Tax | -$79M |
| Income Tax Expense | -$2.2M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$77M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$68M |
| Ebitda | -$66M |
| Net Income | -$77M |
PYXS News
PYXS Profile
Pyxis Oncology Inc Profile
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Pyxis Oncology, Inc., a preclinical biotechnology company, is dedicated to developing antibody-drug conjugate (ADC) and monoclonal antibody (mAb) immunotherapies for treating cancers. The company is headquartered in Cambridge, Massachusetts.
NXTT +2.65%
$0.14
NVDA -2.70%
$167.02
HOUR +93.12%
$3.65
CGBS -39.47%
$0.03
PRSO +68.70%
$1.38
KVUE -9.34%
$18.62
GNPX +47.39%
$0.22
ISPC +27.42%
$0.85
TSLA +3.63%
$350.84
SNAP +3.03%
$7.30
SOUN +7.29%
$14.26
YAAS -63.98%
$0.10
AAL +1.71%
$13.08
RIVN +3.72%
$14.21
VEEE +46.39%
$2.84
AVGO +9.40%
$334.89
AMD -6.58%
$151.13
PLTR -1.79%
$153.34
GELS +62.50%
$1.56
SOFI +0.86%
$25.60
TPIC -45.91%
$0.12
AXDX -61.36%
$0.03
WBD +2.88%
$12.11
MARA +0.52%
$15.19
NIO -2.93%
$5.95
INTC -0.48%
$24.49
HOOD -1.61%
$101.25
AAPL -0.03%
$239.69
LYT -16.77%
$0.09
BBD +3.58%
$3.18
ETHD -2.46%
$3.56
IXHL -9.48%
$0.52
DNN +3.07%
$2.35
F +0.51%
$11.74
BMNR
-0.82%
$41.84
BTG +3.21%
$4.17
BAC -1.12%
$49.77
TLRY +3.47%
$1.19
RMBL +60.50%
$3.21
ADD -25.47%
$0.05
ABEV +1.82%
$2.23
NOK -1.08%
$4.55
RIOT +0.98%
$13.29
LULU -18.57%
$167.80
AMZN -1.42%
$232.33
AEO +0.10%
$18.80
ADAP -19.60%
$0.04
SRM +53.27%
$10.30
GRAB +2.17%
$5.16
ONDS +5.62%
$5.63
PFE +1.38%
$24.88
GOOGL +0.77%
$234.09
LDI +26.75%
$2.89
LCID +13.92%
$18.41
RGTI -0.13%
$15.10
QBTS +0.52%
$15.37
PLUG +1.38%
$1.46
KEY -1.25%
$18.94
EQX +9.03%
$9.77
MSFT -2.55%
$495.00
JBLU -0.19%
$5.08
SBET -3.20%
$14.93
CUTR -10.19%
$0.09
PET -59.91%
$0.04
HBAN -1.29%
$17.64
WLGS -5.57%
$0.04
MU +5.76%
$131.37
CIFR +1.62%
$7.52
AGNC +1.66%
$10.37
JOBY +2.74%
$13.46
RR -0.39%
$2.52
ETWO 0.00%
$3.30
WULF +2.93%
$9.13
BTE -3.31%
$2.18
GOOG +1.07%
$235.17
VALE +1.36%
$10.40
MRVL -1.20%
$63.33
DUO +32.81%
$3.44
T +0.03%
$29.59
HPE +1.55%
$23.52
CAN +3.26%
$0.70
HIMS +0.62%
$48.41
KO -0.42%
$67.95
AFMD -34.94%
$0.18
IREN +0.07%
$26.15
BURU
-5.54%
$0.14
CLF +8.27%
$11.39
ITUB +1.57%
$7.10
PBR -1.63%
$12.17
CMG -0.84%
$41.06
OPAD +4.71%
$5.11
NUVB +14.03%
$3.90
SMCI -0.71%
$40.40
KDP -2.05%
$28.65
CSCO -1.60%
$66.90
FIG
+0.54%
$54.86
WFC -3.50%
$78.95
NVFY +64.79%
$4.40
AG +0.88%
$9.15
AMCR +0.92%
$8.30
NXTT +2.65%
$0.14
NVDA -2.70%
$167.02
HOUR +93.12%
$3.65
CGBS -39.47%
$0.03
PRSO +68.70%
$1.38
KVUE -9.34%
$18.62
GNPX +47.39%
$0.22
ISPC +27.42%
$0.85
TSLA +3.63%
$350.84
SNAP +3.03%
$7.30
SOUN +7.29%
$14.26
YAAS -63.98%
$0.10
AAL +1.71%
$13.08
RIVN +3.72%
$14.21
VEEE +46.39%
$2.84
AVGO +9.40%
$334.89
AMD -6.58%
$151.13
PLTR -1.79%
$153.34
GELS +62.50%
$1.56
SOFI +0.86%
$25.60
TPIC -45.91%
$0.12
AXDX -61.36%
$0.03
WBD +2.88%
$12.11
MARA +0.52%
$15.19
NIO -2.93%
$5.95
INTC -0.48%
$24.49
HOOD -1.61%
$101.25
AAPL -0.03%
$239.69
LYT -16.77%
$0.09
BBD +3.58%
$3.18
ETHD -2.46%
$3.56
IXHL -9.48%
$0.52
DNN +3.07%
$2.35
F +0.51%
$11.74
BMNR
-0.82%
$41.84
BTG +3.21%
$4.17
BAC -1.12%
$49.77
TLRY +3.47%
$1.19
RMBL +60.50%
$3.21
ADD -25.47%
$0.05
ABEV +1.82%
$2.23
NOK -1.08%
$4.55
RIOT +0.98%
$13.29
LULU -18.57%
$167.80
AMZN -1.42%
$232.33
AEO +0.10%
$18.80
ADAP -19.60%
$0.04
SRM +53.27%
$10.30
GRAB +2.17%
$5.16
ONDS +5.62%
$5.63
PFE +1.38%
$24.88
GOOGL +0.77%
$234.09
LDI +26.75%
$2.89
LCID +13.92%
$18.41
RGTI -0.13%
$15.10
QBTS +0.52%
$15.37
PLUG +1.38%
$1.46
KEY -1.25%
$18.94
EQX +9.03%
$9.77
MSFT -2.55%
$495.00
JBLU -0.19%
$5.08
SBET -3.20%
$14.93
CUTR -10.19%
$0.09
PET -59.91%
$0.04
HBAN -1.29%
$17.64
WLGS -5.57%
$0.04
MU +5.76%
$131.37
CIFR +1.62%
$7.52
AGNC +1.66%
$10.37
JOBY +2.74%
$13.46
RR -0.39%
$2.52
ETWO 0.00%
$3.30
WULF +2.93%
$9.13
BTE -3.31%
$2.18
GOOG +1.07%
$235.17
VALE +1.36%
$10.40
MRVL -1.20%
$63.33
DUO +32.81%
$3.44
T +0.03%
$29.59
HPE +1.55%
$23.52
CAN +3.26%
$0.70
HIMS +0.62%
$48.41
KO -0.42%
$67.95
AFMD -34.94%
$0.18
IREN +0.07%
$26.15
BURU
-5.54%
$0.14
CLF +8.27%
$11.39
ITUB +1.57%
$7.10
PBR -1.63%
$12.17
CMG -0.84%
$41.06
OPAD +4.71%
$5.11
NUVB +14.03%
$3.90
SMCI -0.71%
$40.40
KDP -2.05%
$28.65
CSCO -1.60%
$66.90
FIG
+0.54%
$54.86
WFC -3.50%
$78.95
NVFY +64.79%
$4.40
AG +0.88%
$9.15
AMCR +0.92%
$8.30